YLT192
Code | Size | Price |
---|
TAR-T24657-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T24657-50mg | 50mg | £1,661.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T24657-100mg | 100mg | £2,079.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
YLT192 is an orally active and bioavailable VEGFR2 inhibitor. It also has potent antiangiogenic activity and antitumor efficacy.
CAS:
1246566-47-1
Formula:
C21H19N3O4
Molecular Weight:
377.4
Purity:
0.98
SMILES:
CNC(=O)c1cc(Oc2ccc(NC(=O)c3cccc(OC)c3)cc2)ccn1
References
1. Todescan S, Nizar R. Managing patients with necrotizing ulcerative periodontitis. J Can Dent Assoc. 2013;79:d44. Review. PubMed PMID: 23763731.
2. Titball RW. Clostridium perfringens vaccines. Vaccine. 2009 Nov 5;27 Suppl 4:D44-7. doi: 10.1016/j.vaccine.2009.07.047. Review. PubMed PMID: 19837285.
3. Bieniasz PD, Cullen BR. Chemokine receptors and human immunodeficiency virus infection. Front Biosci. 1998 Jan 1;3:d44-58. Review. PubMed PMID: 9407151.
4. Autran B, Plata F, Guillon JM, Joly P, Mayaud C, Debr? P. HIV-specific cytotoxic T lymphocytes directed against alveolar macrophages in HIV-infected patients. Res Virol. 1990 Mar-Apr;141(2):131-6. Review. PubMed PMID: 2189171.